12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test

Key Takeaways

  • Congenital colour deficiency is usually red-green, X-linked recessive, affecting about 8% of males and 0.5% of females.
  • Acquired blue-yellow defects suggest retinal disease and acquired red-green defects suggest optic nerve disease — Köllner's rule.
  • Ishihara plates screen for congenital red-green deficiency and do not detect blue-yellow loss.
  • The Farnsworth D-15 separates mild from clinically significant defects and classifies the axis of confusion.
  • The Farnsworth-Munsell 100-Hue test is the most sensitive clinical test and produces a quantitative error score.
Last updated: September 2026

Physiology and classification

Normal human colour vision is trichromatic, based on three cone photopigments: S (short, blue-sensitive, peak about 420 nm), M (medium, green, about 530 nm) and L (long, red, about 560 nm).

CategoryDescriptionTerminology
Anomalous trichromacyAll three pigments present but one is shiftedProtanomaly (L shifted), deuteranomaly (M shifted), tritanomaly (S shifted)
DichromacyOne pigment entirely absentProtanopia (no L), deuteranopia (no M), tritanopia (no S)
MonochromacyNo colour discriminationRod monochromacy (achromatopsia) — also nystagmus, photophobia and poor acuity

Congenital colour deficiency is overwhelmingly red-green (protan and deutan), X-linked recessive, present in about 8% of males and 0.5% of females. It is stable, bilateral, symmetrical and present from birth, and the patient is often unaware. Deuteranomaly is the most common single type.

Acquired colour deficiency is a different animal: it is often unilateral or asymmetrical, progressive or fluctuating, accompanied by other visual symptoms, and the patient notices it.

Köllner's rule is the interpretive key:

  • Outer retinal disease (macular degeneration, central serous chorioretinopathy, diabetic maculopathy) → blue-yellow (tritan) defects.
  • Optic nerve disease (optic neuritis, compressive optic neuropathy, toxic optic neuropathy) → red-green defects.

The rule has exceptions — glaucoma produces blue-yellow loss despite being an optic neuropathy, and some hereditary maculopathies produce red-green loss — but it is the framework the examination expects.

Drug and toxin causes worth knowing: ethambutol (red-green, dose-related, reversible if caught early), digoxin (yellow-green vision, xanthopsia), hydroxychloroquine, sildenafil-class drugs (transient blue tinge), and methanol.

Pseudoisochromatic plates

Ishihara plates are the standard screening test. Each plate presents a figure of coloured dots against a background of dots that differ in hue but match in brightness and saturation, so the figure can only be seen by hue discrimination.

Plate types: demonstration (seen by everyone, including malingerers), transformation (normal and deficient see different numbers), vanishing (normal sees a number, deficient sees none), hidden digit (deficient sees a number, normal sees none) and classification plates (separate protan from deutan).

Technique, and the errors that invalidate it:

  1. Use natural daylight or a calibrated daylight illuminant — approximately 6500 K. Incandescent light shifts the spectrum and produces false results. This is the most common technique error.
  2. Test one eye at a time — essential for detecting acquired unilateral defects, and routinely skipped.
  3. Hold the book at about 75 cm, plates perpendicular to the line of sight.
  4. Allow about 3 seconds per plate; delayed or hesitant responses are recorded.
  5. Patient wears their near correction.
  6. Record as plates read correctly over plates presented, for example "12/14 OD, 6/14 OS."

Limitations: Ishihara detects red-green deficiency only. It will not detect a tritan defect and therefore cannot be used to screen for acquired retinal disease. Other plate sets include Hardy-Rand-Rittler (HRR), which does test blue-yellow and grades severity, and the Standard Pseudoisochromatic Plates (SPP-2), designed for acquired defects.

Farnsworth D-15

The Farnsworth Panel D-15 is an arrangement test: 15 coloured caps plus a fixed reference cap, which the patient arranges in order of nearest colour resemblance in a tray.

Purpose. It separates mild (pass) from moderate to severe (fail) defects and classifies the axis of the defect. It is not a screening test for mild anomalous trichromacy — many anomalous trichromats pass — which is exactly its value: a failed D-15 means a defect large enough to affect colour-dependent occupations.

Technique: daylight illumination, caps handled by their rims to avoid soiling, one eye at a time, no time pressure but typically a 2-minute guide, and the cap order recorded from the numbers on the underside.

Scoring. The cap order is plotted on a circular diagram and the sequence is joined with lines.

Plot appearanceInterpretation
Caps in order, a smooth circlePass
Crossings running parallel to the protan axisProtan defect
Crossings parallel to the deutan axisDeutan defect
Crossings parallel to the tritan axisTritan defect — suspect acquired retinal disease
Scattered, non-axial crossingsSevere or irregular defect, poor cooperation, or significant acuity loss

A desaturated D-15 (Lanthony) uses paler caps and is more sensitive, catching milder acquired defects that the standard panel misses.

Farnsworth-Munsell 100-Hue

The FM 100-Hue is the most sensitive clinical colour test. Despite the name it uses 85 caps in four trays, each tray covering a portion of the hue circle, which the patient arranges in order between fixed end caps.

Scoring. Each cap receives an error score based on how far its neighbours differ from the correct sequence; the scores are plotted on a polar diagram and summed as a total error score (TES).

Total error scoreInterpretation
0–20Superior discrimination
20–100Average
Over 100Low discrimination

The shape of the polar plot identifies the axis: a bipolar cluster of errors along the protan, deutan or tritan meridian. Scores worsen naturally with age and with reduced acuity, so results must be interpreted against age-matched norms.

Practical drawbacks: it takes 15 to 30 minutes per eye, demands sustained concentration, and is fatiguing. It is reserved for quantifying and monitoring a known defect — serial testing in a patient on ethambutol or hydroxychloroquine, or tracking recovery in optic neuritis — rather than for screening.

Choosing the right test

QuestionTest
Does this child have a congenital red-green deficiency?Ishihara
Is this patient safe for a colour-critical occupation?D-15, plus occupational-specific standards such as lantern tests
Does this patient have an acquired blue-yellow defect suggesting retinal disease?HRR, desaturated D-15, or FM 100-Hue — not Ishihara
How severe is a known defect, and is it progressing?FM 100-Hue with serial total error scores
Is there red desaturation in one eye suggesting optic neuropathy?Bedside red cap comparison between the two eyes, then formal testing

The bedside red cap test deserves its own mention: hold a red object, ask the patient to compare its redness between the two eyes, and ask what percentage of the good eye's red the affected eye sees. A report of "70% as red" is a sensitive early sign of optic nerve dysfunction and takes ten seconds.

Test Your Knowledge

A patient with unilateral progressive vision loss shows a tritan axis defect on the Farnsworth D-15. Applying Köllner's rule, where is the pathology most likely?

A
B
C
D
Test Your Knowledge

Why are Ishihara plates inadequate for screening a patient on hydroxychloroquine for retinal toxicity?

A
B
C
D
Test Your Knowledge

Which illumination is required for valid pseudoisochromatic plate testing?

A
B
C
D
Test Your Knowledge

What is the principal purpose of the Farnsworth D-15 panel test?

A
B
C
D
Test Your Knowledge

A patient reports that a red bottle top looks only 60% as red with the left eye as with the right. What does this suggest?

A
B
C
D